Lynx Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Lynx Biosciences's estimated annual revenue is currently $2.5M per year.
- Lynx Biosciences's estimated revenue per employee is $155,000
Employee Data
- Lynx Biosciences has 16 Employees.
- Lynx Biosciences grew their employee count by -33% last year.
Lynx Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Corporate Development | Reveal Email/Phone |
2 | Chief Business Officer | Reveal Email/Phone |
3 | Quality Control Scientist | Reveal Email/Phone |
4 | CEO/Founder | Reveal Email/Phone |
5 | Principal Scientist | Reveal Email/Phone |
6 | Principal Scientist | Reveal Email/Phone |
7 | Sr Scientist | Reveal Email/Phone |
8 | Senior Research Associate | Reveal Email/Phone |
Lynx Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Lynx Biosciences?
Lynx Biosciences is developing a cytomics-based platform technology to transform blood cancer drug development and deliver precise patient management by identifying the most effective treatment options. Follow us @LynxBio.
keywords:N/AN/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Lynx Biosciences News
2022-03-22 - VC funding update: Which Boston-area startups raised money ...
For the second month in a row, the biotech and life sciences industry took the ... Lynx emerged from stealth with $17.5 million in funding,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.4M | 16 | N/A | N/A |
#2 | $1.4M | 16 | N/A | N/A |
#3 | $1.4M | 16 | N/A | N/A |
#4 | $1.2M | 16 | -48% | $22.9M |
#5 | $1.4M | 16 | 7% | N/A |